Tim Lohoff

Tim Lohoff, Ph.D., currently serves as a Senior Associate at Forbion, a prominent venture capital firm specializing in life sciences, where involvement includes managing multiple funds totaling approximately €3bn. In addition to this role, Tim holds positions as a Board Observer for several companies, including AIRNA, Seamless Therapeutics, AAVantgarde Bio, and Kynexis. Prior experience includes working as a Life Sciences Specialist at L.E.K. Consulting and conducting doctoral research at the University of Cambridge, focusing on stem cell biology and cell fate commitment. Tim's academic background encompasses extensive studies in regenerative biology and medicine from institutions such as the University of Cambridge, Quantic School of Business and Technology, and Bielefeld University, underscoring a strong foundation in both scientific and business disciplines.